How many years of comparable data are there for Angola and Kenya?

39 years are reported by both, from 1980 to 2018.

Where does this data come from?

World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Angola vs Kenya: Statin use vs. average non-HDL cholesterol levels

Angola

2.8

in 2018

Kenya

2.8

in 2018

Angola rank

163rd

Kenya rank

163rd

Statin use vs. average non-HDL cholesterol levels over time

Angola
Kenya

How they compare

Angola currently reports 2.8 against 2.8 in Kenya, a difference of 0.

The two have swapped places 1 time across 39 shared years of data; in 1980 it was Angola ahead.

Angola ranks 163rd and Kenya ranks 163rd of 191 countries.

Angola has averaged higher in every one of the 4 decades both report.

Head to head by decade

Decade	Angola	Kenya	Difference	Ahead
1980s	2.57	2.38	0.19	Angola
1990s	2.75	2.52	0.23	Angola
2000s	2.83	2.64	0.19	Angola
2010s	2.84	2.77	0.0778	Angola

Averages of every year both report within each decade.

Frequently asked questions

Which has higher statin use vs. average non-hdl cholesterol levels, Angola or Kenya?: Angola, at 2.8 against 2.8 in Kenya as of 2018.
What is the difference in statin use vs. average non-hdl cholesterol levels between Angola and Kenya?: 0, with Angola ahead.
How many years of comparable data are there for Angola and Kenya?: 39 years are reported by both, from 1980 to 2018.
How do Angola and Kenya rank globally for statin use vs. average non-hdl cholesterol levels?: Angola ranks 163rd and Kenya ranks 163rd of 191 countries.
Where does this data come from?: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

About this data

Indicator: Statin use vs. average non-HDL cholesterol levels
Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence: CC BY 4.0 (Our World in Data)
Coverage: 191 places, 7,449 data points, 1980–2018
Last refreshed: 07 August 2026

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.